Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 4767 (MIR4767) is a human microRNA gene producing a non-coding RNA molecule involved in post-transcriptional regulation of gene expression. Like other microRNAs, it functions by base-pairing with target messenger RNAs (mRNAs), leading to mRNA degradation or inhibition of translation. In human vascular endothelial cells, miR-4767 has been shown experimentally to promote apoptosis by targeting and downregulating expression of the apoptosis inhibitor BCL2-like 12 (BCL2L12). Its cellular roles are not well characterized beyond this function, and there are no approved drugs or known direct pharmacological modulators. MIR4767 is associated with certain dermatological diseases by gene association but without established mechanistic links to pathogenesis. At present, MIR4767 is not considered a canonical therapeutic target such as a receptor, enzyme, transporter, or transcription factor.
Not applicable; no direct drug interaction reported
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 4767 (MIR4767).